Perella Weinberg
Perella Weinberg Partners is an independent, privately-owned financial services firm that provides corporate advisory and asset management services to clients around the world. The Firm has assembled a group of talented and experienced professionals recruited from a wide variety of leading global financial institutions.
View Older Stories View More Recent Stories
-
E.ON sees job cuts, synergies in German utilities shake-up
-
Orexigen Therapeutics (OREX) to File Chapter 11 Bankruptcy
-
Orexigen Therapeutics, Inc. Plans For Near-term Sale Using Structured Process Through Chapter 11 Of U.S. Bankruptcy Code
-
Form X-17A-5 PERELLA WEINBERG PARTNER For: Dec 31
-
360Training Announces Investment from PWP Growth Equity and RedHawk Investment
-
Fieldwood Energy Files Prepackaged Chapter 11 Cases and Announces Gulf of Mexico Acquisition
-
Form 13F-HR Perella Weinberg Partner For: Dec 31
-
XOJET Closed 2017 with 5 Years of Unprecedented Growth, over 30% increase in charter brokerage and accelerated investment in its core business operations, positioning the company for breakout growth a
-
Form SC 13G Oasis Midstream Partners Filed by: Perella Weinberg Partners Capital Management LP
-
Granite Construction (GVA) to Acquire Layne Christensen (LAYN) for $565M in Stock
-
Granite Construction to Acquire Layne Christensen in $565 Million Stock Merger Transaction
-
Remington Outdoor Company Announces Restructuring Support Agreement with Creditors for a Comprehensive Financial Restructuring and $145 million of New Capital
-
Seattle Genetics (SGEN) to Acquire Cascadian Therapeutics (CASC) for $10/Share
-
Seattle Genetics to Acquire Cascadian Therapeutics, Adding Late-Stage Breast Cancer Program to Its Oncology Pipeline
-
AIG to buy reinsurer Validus for $5.56 billion
-
AIG (AIG) to Acquire Validus (VR) for $5.56 Billion
-
AIG to Acquire Validus for $5.56 Billion in Cash
-
Delphon Announces PWP Growth Equity Investment
-
Perella Weinberg Partners Opens Chicago Office; Names Brennan Smith Partner
-
Carrick Capital Partners Announces Promotions of Paul Zolfaghari and Chris Wenner
-
CEOs go M&A hunting as booming markets unleash dealmaking spirits
-
Perella Weinberg Partners Announces New Partners
-
Jacobs Completes CH2M Acquisition, Creating $15 Billion Professional Services Leader Focused on Delivering Innovative Solutions for a More Connected, Sustainable World
-
PWP Growth Equity Names Daniel H. Leever Operating Partner
-
Global Brokerage, Inc. Receives Approximately 78.5% Yes Votes to Move Forward with the Prepackaged Plan of Reorganization
-
High Water Women to Hold Fifth Symposium on Impact Investing
-
Form 13F-HR Perella Weinberg Partner For: Sep 30
-
Global Brokerage, Inc. Announces Entry Into Restructuring Support Agreement with Approximately 70% of Noteholders; Also Announces Delisting from NASDAQ Global Market, Transfers to NASDAQ Capital Marke
-
KBRA Assigns Preliminary Ratings to Notes Issued by Flagship Credit Auto Trust 2017-4
-
Strayer Education (STRA) and Capella Education (CPLA) Agree to All-Stock Merger
-
Strayer Education, Inc. and Capella Education Company Combine to Create a National Leader in Education Innovation
-
Amita Schultes Joins Perella Weinberg Partners Agility as Managing Director
-
Form D/A Perella Weinberg Partner
-
Form D/A Perella Weinberg Partner
-
Refinancing: Oxea Issues EUR 900 Million Equivalent First Lien Term Loan, Upsizes Revolving Credit Facility
-
Luna Grill Announces PWP Growth Equity Investment
-
Quidel Corp (QDEL) Gains After Revised Deal on Alere's (ALR) BNP Assay Business
-
Northrop Grumman to Acquire Orbital ATK for $9.2 Billion
-
Quidel Announces Revised Agreement for Its Pending Acquisition of Alere’s B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers
-
Northrop Grumman to Acquire Orbital ATK for $9.2 Billion
-
Northrop Grumman to Acquire Orbital ATK for $9.2 Billion
-
Northrop Grumman to buy missile maker Orbital for $7.8 billion
-
Northrop Grumman (NOC) to Acquire Orbital ATK (OA) for $7.8B
-
Northrop Grumman to Acquire Orbital ATK for $9.2 Billion
-
Aspen Institute Launches The Aspen Economic Strategy Group
-
Inotek Pharma (ITEK) to Merge with Rocket Pharmaceuticals
-
Inotek Pharmaceuticals Announces Merger Agreement with Rocket Pharmaceuticals to Advance Pipeline of First-in-Class Gene Therapies for Rare Diseases
-
Vasuda Capital Management Seeks to Inspects Books and Records of Inotek Pharmaceuticals (ITEK) Related to Potential Sale
-
Form 13F-HR Perella Weinberg Partner For: Jun 30
-
Concordia International Corp. Announces Second Quarter 2017 Results

